MedTrace Logo

Botulinum Toxin A in the Treatment of Hemifacial Spasm

NCT03306940 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-10-12

No results posted yet for this study

Summary

Hemifacial spasm patients who received botulinum toxin A injection were divided into two groups. Group A received unilateral injection while group B received bilateral injection. Patients completed follow-up A researcher record facial videos and analyzed facial symmetry and completed 3 scales.

Conditions

  • Hemifacial Spasm

Interventions

DRUG

Botulinum Toxin Type A

patients were injected to the normal side with dose of 1.25 units/per site

Sponsors & Collaborators

  • Tongji University

    lead OTHER

Principal Investigators

  • Lingjing Jin, PhD · Shanghai Tongji Hospital, Tongji University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-02
Primary Completion
2018-07-31
Completion
2018-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03306940 on ClinicalTrials.gov